What is the latest price of axitinib/axitinib in 2025

Axitinib/Axitinib belongs to the kinase inhibitor class of drugs. It works by blocking the activity of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Axitinib is used alone to treat advanced renal cell carcinoma (RCC), a cancer that starts in the cells of the kidneys, in patients who have not responded to another drug. Axitinib is used in combination with avelumab or pembrolizumab to treat advanced renal cell carcinoma.

Axitinib is available as an oral tablet. Usually taken twice a day, with or without food. Take axitinib at approximately the same time each day, approximately 12 hours apart. Take axitinib exactly as directed. Do not take more or less than prescribed by your doctor. Swallow the tablets whole with a glass of water; do not cut, chew, or crush them. If a patient vomits after taking axitinib, do not take additional doses. Continue regular dosing schedule. Doctors may start patients on a low dose of axitinib and gradually increase the dose no more than once every two weeks, depending on how well the drug works for the patient and the side effects they may experience.

The original drug of axitinib has been launched in China and has been included in the reimbursement scope of Class B medical insurance. Common specifications include1mg*14 tablets, 5mg*28 tablets, etc. Each box may be sold for more than 2,000 yuan. At the same time, the original research version sold overseas may cost around 6,000 yuan per box.

At the same time, there are also generic axitinib drugs on the market overseas. Their drug ingredients are basically the same as those of the original research, such as the Laos version, the Indian version and the Bangladeshi version. Each box may be sold for around around 1,000 yuan (the price may fluctuate due to exchange rates).

Reference materials:https://medlineplus.gov/druginfo/meds/a612017.html